Executive Director

Rosemary Molinari

Rosemary Molinari, Executive Director, provides overall leadership to all functions, cohesively addressing risk management and strategic planning to support core teams throughout the study. Rosemary has 25 years of Fortrea experience with expertise in managing Phase I through IV studies from protocol development through to submissions to regulatory authorities. She has experience in both global and North American studies in the areas of Type 1 and Type 2 diabetes, CV and cardiovascular outcome studies.

お客様のニーズに応える当社のソリューション。

Fortrea はフェーズ I から IV までの治験管理、臨床薬理、患者様アクセスソリューション、その他業務を実現するサービスの総合的なプロバイダーとして、バイオ医薬品、医療機器、診断の各分野の新興企業や大手企業と提携し、革新的なヘルスケアを世界中に促進するべく取り組んでいます。